Noisy
← this week  ·  Subscribe →

The world is being quietly rearranged by people who write very long documents.

Federal Register · April 22, 2026
The title they went with Medical Devices; Clinical Chemistry and Clinical Toxicology Devices; Classification of the Setmelanotide Eligibility Gene Variant Detection System Noisy translates that to

A new genetic test for obesity drugs gets a faster path to market

What happened
US health regulators are making it easier to approve a new type of genetic test. This test helps doctors decide if a specific obesity drug will work for a patient.
Why it matters
For years, new medical devices faced a slow, expensive approval process, even for minor variations. This change means that once a new category of device is approved, similar devices can get to market faster. This could speed up access to personalized medicine, where treatments are tailored to a patient's genetic makeup.
The signal
Watch how quickly other genetic tests for similar targeted therapies get approved under this new, faster process.
If you insist
Read the original →